LIN−HLA−DR−CD33+CD11b+ MDSCs have been identified in patients of glioblastoma, breast cancer, colon cancer, lung cancer, and kidney cancer [14, 15, 26–28]. This evidence concerns the gene ITGAM and breast carcinoma.